Eagle Health Investments »

Ascendis Pharma A S shares owned by Eagle Health Investments

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Eagle Health Investments from 13F filings

Historical chart of Eagle Health Investments investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Eagle Health Investments

Quarter filed Position value Share count Share price at filing
2025-03-31 $8.8M 57k 155.86

More positions owned by Eagle Health Investments

Argenx Se Sponsored Adr (ARGX)
Icon SHS (ICLR)
Natera (NTRA)
Insmed Com Par $.01 (INSM)
Illumina (ILMN)
Guardant Health (GH)
Neurocrine Biosciences (NBIX)
BioMarin Pharmaceutical (BMRN)
Fortrea Hldgs Common Stock (FTRE)
Bridgebio Pharma (BBIO)
Scholar Rock Hldg Corp (SRRK)
EXACT Sciences Corporation (EXAS)
Terns Pharmaceuticals (TERN)
Kymera Therapeutics (KYMR)
Compass Pathways Sponsored Ads (CMPS)

View all positions for Eagle Health Investments

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Lombard Odier Asset Management
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
T. Rowe Price Investment Management
Massachusetts Financial Services
Wellington Management Company
Franklin Resources
Perceptive Advisors
Principal Financial Group
Invesco

View all funds holding Ascendis Pharma A S